Amanote Research

Amanote Research

  • Register
  • Sign In

Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker

Journal of Stroke- South Korea

doi 10.5853/jos.2018.00962

Full Text

Abstract

Available in

Categories

NeurologyCardiovascular MedicineCardiology

Date

September 30, 2018

Authors

Hye Youn SungJi Yeoun LeeAe Kyung ParkYoun Joo MoonInho JoEun-Mi ParkKyu-Chang WangJi Hoon PhiJung-Hyuck AhnSeung-Ki Kim

Publisher

Korean Stroke Society


Related search

Sortilin 1 (SORT1)

Science-Business eXchange
2010English

Identification of Radiation-Induced Aberrant Hypomethylation in Colon Cancer

BMC Genomics
BiotechnologyGenetics
2015English

Moyamoya Disease

CMAJ
Medicine
2018English

Moyamoya Disease

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

Moyamoya Disease

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2014English

Aberrant Gene Promoter Methylation Marking Disease Progression in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-Moyamoya Disease

Neurologia Medico-Chirurgica
SurgeryNeurology
2019English

Significant Association of EED Promoter Hypomethylation With Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2019English

MRA of Moyamoya Disease

Surgery for Cerebral Stroke
1994English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy